A team that includes researchers from Emory University released findings Tuesday of closely-watched work to create a COVID-19 vaccine that showed some positive results, but more work is needed to be sure it is safe.
The findings showed high levels of neutralizing antibody activity that were above the average levels seen in blood serum obtained from people recovering from the disease, Emory’s team said.
No serious side effects were found, researchers said, but more than half of the 45 trial study patients said they suffered fatigue, headaches and chills. Researchers said the side effects were more prevalent among the patients who received the strongest of the three dosages tested.
A lead Emory researcher called the results encouraging.
“While there is still a lot of work to do before we have a vaccine that is proven to be safe and effective against COVID-19, this study provides critical information about the safety of the vaccine,” said Dr. Evan Anderson, an associate professor of medicine and pediatrics at Emory University School of Medicine and Children’s Healthcare of Atlanta. “Importantly, the vaccine resulted in a robust immune response.”
